Literature DB >> 634875

Acute renal failure from the use of acetazolamide (Diamox).

T Higenbottam, C S Ogg, H M Saxton.   

Abstract

The clinical histories of two patients are presented, who both developed haemorrhagic anuria after a short course of therapy with the carbonic anhydrase inhibitor, acetazolamide (Diamox). The clinical findings, in particular the radiological changes, are illustrated in this potentially fatal condition. The therapeutic success of immediate relief of the ureteric obstruction is emphasized and it is hoped that this report will act as a reminder of the importance of this agent as a cause of anuria.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 634875      PMCID: PMC2425061          DOI: 10.1136/pgmj.54.628.127

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  4 in total

1.  Renal failure associated with acetazolamide therapy for glaucoma.

Authors:  S A Howlett
Journal:  South Med J       Date:  1975-04       Impact factor: 0.954

2.  Thrombocytopenia and renal lesions associated with acetazoleamide (diamox) therapy.

Authors:  J R BERTINO; T RODMAN; R M MYERSON
Journal:  AMA Arch Intern Med       Date:  1957-06

3.  Twenty-nine children with sulphonamide haematuria.

Authors:  G C ARNEIL
Journal:  Lancet       Date:  1958-04-19       Impact factor: 79.321

4.  The incidence, importance, and prophylaxis of acute mountain sickness.

Authors:  P H Hackett; D Rennie; H D Levine
Journal:  Lancet       Date:  1976-11-27       Impact factor: 79.321

  4 in total
  3 in total

Review 1.  Chronic open-angle glaucoma. Review for primary care physicians.

Authors:  Feisal A Adatia; Karim F Damji
Journal:  Can Fam Physician       Date:  2005-09       Impact factor: 3.275

2.  Acetazolamide and symptomatic metabolic acidosis in mild renal failure.

Authors:  D N Maisey; R D Brown
Journal:  Br Med J (Clin Res Ed)       Date:  1981-12-05

3.  Anuric Acute Kidney Injury Induced by Acute Mountain Sickness Prophylaxis With Acetazolamide.

Authors:  Javier A Neyra; James Castle Alvarez-Maza; James E Novak
Journal:  J Investig Med High Impact Case Rep       Date:  2014-04-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.